S Jaishankar to embark on 5-day US visit from 24 May; likely to discuss vaccine procurement, production

The External Affairs Minister will also hold interactions with business forums on economic and COVID-related cooperation between India and US

Press Trust of India May 21, 2021 14:05:14 IST
S Jaishankar to embark on 5-day US visit from 24 May; likely to discuss vaccine procurement, production

File image of External Affairs Minister S Jaishankar. AFP

New Delhi: External Affairs Minister S Jaishankar will begin a five-day visit to the United States from Monday with a focus on procurement of coronavirus vaccines from American companies as well as explore the possibility of their joint production.

The Ministry of External Affairs said Jaishankar will hold discussions with US Secretary of State Antony Blinken besides meeting senior officials of the Biden administration during his visit from 24 to 28 May.

In New York, Jaishankar is expected to meet UN Secretary-General Antonio Guterres.

"In Washington DC, the External Affairs Minister will hold discussions with his counterpart Secretary of State Antony Blinken. He will also be meeting Cabinet members and Senior Officials of the Administration dealing with the bilateral relationship," the MEA said in a statement.

It said he will have two interactions with business forums on economic and COVID-related cooperation between the two countries.

Updated Date:

also read

Centre increases gap between Covishield doses to 12-16 weeks: All you need to know
India

Centre increases gap between Covishield doses to 12-16 weeks: All you need to know

This is the third time in three months that the Central Government has widened the intervals between Covishield doses

DCGI approves phase II/III trials of Covaxin on children between 2 to 18 years
India

DCGI approves phase II/III trials of Covaxin on children between 2 to 18 years

The Union Health Ministry said that the clinical trials will be conducted on 525 healthy volunteers from the age group

India lauds patent waiver under WTO agreement, move will enable ramping up manufacturing of COVID vaccines
India

India lauds patent waiver under WTO agreement, move will enable ramping up manufacturing of COVID vaccines

US had backed the initiative by India and South Africa, which sought relaxation in the TRIPS agreement norms to ensure availability and affordability of vaccines